Prognostic Significance of Lung and Cava Vein Ultrasound in Elderly Patients Admitted for Acute Heart Failure: PROFUND-IC Registry Analysis
Introduction: Heart failure is an extremely prevalent disease in the elderly population of the world. Most patients present signs and symptoms of decompensation of the disease due to worsening congestion. This congestion has been clinically assessed through clinical signs and symptoms and complementary imaging tests, such as chest radiography. Recently, pulmonary and inferior vena cava ultrasound has been shown to be useful in assessing congestion but its prognostic significance in elderly patients has been less well evaluated. Objectives: This study aims to compare the clinical and radiological characteristics and predictive values for mortality in patients admitted for heart failure through the determination of B lines by lung ultrasound and the degree of collapsibility of the inferior vena cava (IVC). Secondarily, the study aims to assess the prediction of 30-day mortality based on the diameter of the IVC by means of the ROC curve. Methods: This is an observational cohort study based on data collected in the PROFUND-IC study, a nationwide multicentric registry of patients admitted with decompensated heart failure. Data were collected from these patients between October 2020 and April 2022. Results: A total of 482 patients were entered into the PROFUND-IC registry between October 2020 and April 2022. Bedside clinical ultrasound was performed during admission in 301 patients (64.3%). The number of patients with more than 6 B-lines on lung ultrasound amounted to 194 (66%). Statistically significant differences in 30-day mortality (22.1% vs. 9.2%; <i<p</i< = 0.01) were found in these patients. The sum of patients with IVC collapsibility of less than 50% amounted to 195 (67%). Regarding prognostic value, collapsibility data were significant for the number of admissions in the last year (12.5% vs. 5.5%; <i<p</i< = 0.04), in-hospital mortality (10.1% vs. 3.3%, <i<p</i< = 0.04) and 30-day mortality (22.6% vs. 8.1%; <i<p</i< < 0.01), but not for readmissions. Regarding the prognostic value of IVC diameter for 30-day mortality, the area under the ROC curve (AUC) was 0.73, with a <i<p</i< < 0.01. The curve cut-off point with the highest sensitivity (70%) and specificity (70.3%) was for an IVC value of 22.5 mm. In the logistic regression analysis, we observed that the variable most associated with patient survival at 30 days was the presence of a collapsible inferior vena cava, with more than 50% OR 0.359 (CI 0.139–0.926; <i<p</i< = 0.034). Conclusions: The subgroups of patients analyzed with more than six B lines per field and IVC collapsibility less than or equal to 50%, as measured by clinical ultrasound, had higher 30-day mortality rates than patients who did not fall into these subgroups. IVC diameter may be a good independent predictor of 30-day mortality in patients with decompensated heart failure. Comparing both ultrasound variables, it seems that in our population, the assessment of the inferior vena cava may be more associated with short-term prognosis than the pulmonary congestion variables assessed by B lines..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Journal of Clinical Medicine - 11(2022), 15, p 4591 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sara Pérez-Herrero [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
B lines |
|---|
| doi: |
10.3390/jcm11154591 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ016706412 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ016706412 | ||
| 003 | DE-627 | ||
| 005 | 20240414113019.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/jcm11154591 |2 doi | |
| 035 | |a (DE-627)DOAJ016706412 | ||
| 035 | |a (DE-599)DOAJ0f16c2fba010426abe3528cd164f347b | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a Sara Pérez-Herrero |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prognostic Significance of Lung and Cava Vein Ultrasound in Elderly Patients Admitted for Acute Heart Failure: PROFUND-IC Registry Analysis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Introduction: Heart failure is an extremely prevalent disease in the elderly population of the world. Most patients present signs and symptoms of decompensation of the disease due to worsening congestion. This congestion has been clinically assessed through clinical signs and symptoms and complementary imaging tests, such as chest radiography. Recently, pulmonary and inferior vena cava ultrasound has been shown to be useful in assessing congestion but its prognostic significance in elderly patients has been less well evaluated. Objectives: This study aims to compare the clinical and radiological characteristics and predictive values for mortality in patients admitted for heart failure through the determination of B lines by lung ultrasound and the degree of collapsibility of the inferior vena cava (IVC). Secondarily, the study aims to assess the prediction of 30-day mortality based on the diameter of the IVC by means of the ROC curve. Methods: This is an observational cohort study based on data collected in the PROFUND-IC study, a nationwide multicentric registry of patients admitted with decompensated heart failure. Data were collected from these patients between October 2020 and April 2022. Results: A total of 482 patients were entered into the PROFUND-IC registry between October 2020 and April 2022. Bedside clinical ultrasound was performed during admission in 301 patients (64.3%). The number of patients with more than 6 B-lines on lung ultrasound amounted to 194 (66%). Statistically significant differences in 30-day mortality (22.1% vs. 9.2%; <i<p</i< = 0.01) were found in these patients. The sum of patients with IVC collapsibility of less than 50% amounted to 195 (67%). Regarding prognostic value, collapsibility data were significant for the number of admissions in the last year (12.5% vs. 5.5%; <i<p</i< = 0.04), in-hospital mortality (10.1% vs. 3.3%, <i<p</i< = 0.04) and 30-day mortality (22.6% vs. 8.1%; <i<p</i< < 0.01), but not for readmissions. Regarding the prognostic value of IVC diameter for 30-day mortality, the area under the ROC curve (AUC) was 0.73, with a <i<p</i< < 0.01. The curve cut-off point with the highest sensitivity (70%) and specificity (70.3%) was for an IVC value of 22.5 mm. In the logistic regression analysis, we observed that the variable most associated with patient survival at 30 days was the presence of a collapsible inferior vena cava, with more than 50% OR 0.359 (CI 0.139–0.926; <i<p</i< = 0.034). Conclusions: The subgroups of patients analyzed with more than six B lines per field and IVC collapsibility less than or equal to 50%, as measured by clinical ultrasound, had higher 30-day mortality rates than patients who did not fall into these subgroups. IVC diameter may be a good independent predictor of 30-day mortality in patients with decompensated heart failure. Comparing both ultrasound variables, it seems that in our population, the assessment of the inferior vena cava may be more associated with short-term prognosis than the pulmonary congestion variables assessed by B lines. | ||
| 650 | 4 | |a heart failure | |
| 650 | 4 | |a clinical ultrasound | |
| 650 | 4 | |a B lines | |
| 650 | 4 | |a inferior vena cava | |
| 650 | 4 | |a mortality | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a Noel Lorenzo-Villalba |e verfasserin |4 aut | |
| 700 | 0 | |a Elena Urbano |e verfasserin |4 aut | |
| 700 | 0 | |a Beatriz Sánchez-Sauce |e verfasserin |4 aut | |
| 700 | 0 | |a Fernando Aguilar-Rodríguez |e verfasserin |4 aut | |
| 700 | 0 | |a Máximo Bernabeu-Wittel |e verfasserin |4 aut | |
| 700 | 0 | |a Rocio Garcia-Alonso |e verfasserin |4 aut | |
| 700 | 0 | |a Llanos Soler-Rangel |e verfasserin |4 aut | |
| 700 | 0 | |a Francisco Trapiello-Valbuena |e verfasserin |4 aut | |
| 700 | 0 | |a Alejandra Garcia-García |e verfasserin |4 aut | |
| 700 | 0 | |a Jose Manuel Casas-Rojo |e verfasserin |4 aut | |
| 700 | 0 | |a Luis Beltrán-Romero |e verfasserin |4 aut | |
| 700 | 0 | |a Lucia De Jorge-Huerta |e verfasserin |4 aut | |
| 700 | 0 | |a Juan Igor Molina-Puente |e verfasserin |4 aut | |
| 700 | 0 | |a Emmanuel Andrès |e verfasserin |4 aut | |
| 700 | 0 | |a Rosario Iguarán-Bermúdez |e verfasserin |4 aut | |
| 700 | 0 | |a Manuel Méndez-Bailón |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Journal of Clinical Medicine |d MDPI AG, 2013 |g 11(2022), 15, p 4591 |w (DE-627)DOAJ000006793 |x 20770383 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2022 |g number:15, p 4591 |
| 856 | 4 | 0 | |u https://doi.org/10.3390/jcm11154591 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/0f16c2fba010426abe3528cd164f347b |z kostenfrei |
| 856 | 4 | 0 | |u https://www.mdpi.com/2077-0383/11/15/4591 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2077-0383 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2022 |e 15, p 4591 | ||